IP Verse

Hamm&wittkopp Patentanwälte Partmbb competitive analysis

Latest oppositions filed by Hamm&wittkopp Patentanwälte Partmbb

Explore patent oppositions filed by Hamm&wittkopp Patentanwälte Partmbb against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 20, 2026
Patent NumberTitleApplicantOpposition Date
EP4209493
Solid Forms And Formulations Of (S)-4-(8-Amino-3-(1-(But-2-Ynoyl)Pyrrolidin-2-Yl)Imidazo[1,5-A]Pyrazin-1-Yl)-N-(Pyridin-2-Yl)BenzamideACERTA PHARMAAug 11, 2026
EP3984538
Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla GeneAMICUS THERAPEUTICSAug 3, 2026
EP2882444
Microporous Zirconium Silicate For Treating HyperkalemiaZS PHARMAJun 17, 2026
EP2965752
Pharmaceutical Formulation Comprising EzetimibeASSIA CHEMICAL INDUSTRIESJun 3, 2026
EP4385509
Migalastat Formulations Having Improved PharmacokineticsAMICUS THERAPEUTICSJun 2, 2026
EP4034122
Methods For Treating HyperphenylalaninemiaPTC THERAPEUTICS MPMay 12, 2026
EP4426307
New Oral Pharmaceutical Composition And Dose Regimen For The Therapy Of Progressive Fibrosing Interstitial Lung DiseasesBOEHRINGER INGELHEIMApr 2, 2026
EP3449911
Pharmaceutical FormulationsARRAY BIOPHARMAMar 18, 2026
EP3435996
Methods Of Treatment Of Cholestatic DiseasesGENFITJan 29, 2026
EP3592732
Manufacture Of A Crystalline Pharmaceutical ProductORIONJan 8, 2026

Latest PTAB cases involving Hamm&wittkopp Patentanwälte Partmbb

Discover the latest PTAB cases involving Hamm&wittkopp Patentanwälte Partmbb, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hamm&wittkopp Patentanwälte Partmbb with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 20, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HAMM&WITTKOPP PATENTANWÄLTE PARTMBB74 - - -
AMGEN9146811
JANSSEN PHARMACEUTICA165 - 1
NOVARTIS6467 - 21